1. Digital N. National Diabetes Foot care Audit Report (NDFA) 2018.
2. Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability. Diabetic Medicine [Internet]. 2018 May 23.
3. James S, Abate D, Abate H, Abay SM. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789-858.
4. Kerr M. Foot care in diabetes: the human and financial cost. NICE; 2017.
5. Bus SA, van Netten JJ. A shift in priority in diabetic foot care and research: 75% of foot ulcers are preventable. Diabetes/Metabolism Research & Reviews. 2016;32:195-200.
6. Bus SA, Lavery LA, Monteiro‐Soares M, Rasmussen A, Raspovic A, Sacco IC, et al. Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update). Diabetes/Metabolism research and reviews [Internet]. 2020; 36:[e3269 p.].
7. Paton J, Bruce G, Jones R, Stenhouse E. Effectiveness of insoles used for the prevention of ulceration in the neuropathic diabetic foot: a systematic review. Journal of Diabetes and its Complications. 2011;25(1):52-62.
8. Bus SA, Deursen RW, Armstrong DG, Lewis JEA, Caravaggi CF, Cavanagh PR, et al. Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review. Diabetes/Metabolism Research & Reviews. 2016;32:99-118.
9. van Netten JJ, Price PE, Lavery LA, Monteiro-Soares M, Rasmussen A, Jubiz Y, et al. Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review. Diabetes/Metabolism Research And Reviews. 2016;32 Suppl 1:84-98.
10. Crawford F, Nicolson DJ, Amanna AE, Martin A, Gupta S, Leese GP, et al. Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia. 2020;63(1):49-64.
11. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new Medical Research Council guidance. British Medical Journal [Internet]. 2008; 337:[a1655 p.].
12. Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ (Clinical research ed). 2021;374:n2061.
13. Game FL, Apelqvist J, Attinger C, Hartemann A, Hinchliffe RJ, Löndahl M, et al. Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review. Diabetes/metabolism research and reviews. 2016;32.
14. Jeffcoate WJ, Bus SA, Game FL, Hinchliffe RJ, Price PE, Schaper NC. Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality. The Lancet Diabetes & Endocrinology. 2016;4(9):781-8.
15. Thabane L, Ma J, Chu R, Cheng J, Ismaila A, Rios LP, et al. A tutorial on pilot studies: the what, why and how. BMC Medical Research Methodology. 2010;10(1):1.
16. Eldridge SM, Lancaster GA, Campbell MJ, Thabane L, Hopewell S, Coleman CL, et al. Defining feasibility and pilot studies in preparation for randomised controlled trials: development of a conceptual framework. PloS one. 2016;11(3):e0150205.
17. Nickinson ATO, Bridgwood B, Houghton JSM, Nduwayo S, Pepper C, Payne T, et al. A systematic review investigating the identification, causes, and outcomes of delays in the management of chronic limb-threatening ischemia and diabetic foot ulceration. Journal of vascular surgery. 2020;71(2):669-81.
18. Collings R, Freeman JA, Latour J, Vickery PJ, Glasser S, Lepesis V, et al. INSoles To Ease Pressure (INSTEP) Study: a multicentre, randomised controlled feasibility study to compare the effectiveness of a novel instant optimised insole with a standard insole for people with diabetic neuropathy: a study protocol. BMJ open [Internet]. 2019 Mar 2019; 9(3):[e029185 p.].
19. Paisey R, Abbott A, Paisey C, Walker D, Birch R, Bowen B, et al. Diabetic foot ulcer incidence and survival with improved diabetic foot services: an 18‐year study. Diabetic Medicine. 2019;36(11):1424-30.
20. Holman N, Knighton P, Wild SH, Sattar N, Dew C, Gregg EW, et al. Cohort profile: National Diabetes Audit for England and Wales. Diabetic Medicine. 2021:e14616.
21. Feng Y, Schlösser FJ, Sumpio BE. The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy. Journal of Vascular Surgery. 2009;50(3):675-82.
22. Mueller MJ. Identifying patients with diabetes mellitus who are at risk for lower-extremity complications: use of Semmes-Weinstein monofilaments. Physical Therapy. 1996;76(1):68-71.
23. Ahroni JH, Boyko EJ, Forsberg R. Reliability of F-Scan in-shoe measurements of plantar pressure. Foot & Ankle International [Internet]. 1998; 19(10):[668-73 pp.].
24. Mueller MJ, Hastings M, Commean PK, Smith KE, Pilgram TK, Robertson D, et al. Forefoot structural predictors of plantar pressures during walking in people with diabetes and peripheral neuropathy. Journal of Biomechanics. 2003;36(7):1009-17.
25. Mueller MJ, Minor SD, Sahrmann SA, Schaaf JA, Strube MJ. Differences in the gait characteristics of patients with diabetes and peripheral neuropathy compared with age-matched controls. Physical therapy. 1994;74(4):299-308.
26. Arts MLJ, Bus SA. Twelve steps per foot are recommended for valid and reliable in-shoe plantar pressure data in neuropathic diabetic patients wearing custom made footwear. Clinical Biomechanics. 2011;26(8):880-4.
27. Collings R, Freeman J, Latour J, Paton J. Abstracts from the College of Podiatry Annual Conference 2019. Journal of Foot and Ankle Research. 2021;14(1):23.
28. Healy A, Dunning DN, Chockalingam N. Effect of insole material on lower limb kinematics and plantar pressures during treadmill walking. Prosthetics & Orthotics International (Taylor & Francis Ltd). 2011;36(1):53-62.
29. Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts. Annals of Medicine. 2017;167(1):40-7.
30. Eldridge SM, Chan CL, Campbell MJ, Bond CM, Hopewell S, Thabane L, et al. CONSORT 2010 statement: extension to randomised pilot and feasibility trials. British Medical Journal [Internet]. 2016 Oct 24 Pmc5076380]; 355:[i5239 p.].
31. Bang H, Ni L, Davis CE. Assessment of blinding in clinical trials. Controlled Clinical Trials. 2004;25(2):143-56.
32. Lincoln N, Jeffcoate W, Ince P, Smith M, Radford K. Validation of a new measure of protective footcare behaviour: the Nottingham Assessment of Functional Footcare (NAFF). Practical Diabetes International. 2007;24(4):207-11.
33. Booth M. Assessment of Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport. 2000;71(sup2):114-20.
34. Kallio H, Pietilä AM, Johnson M, Kangasniemi M. Systematic methodological review: developing a framework for a qualitative semi‐structured interview guide. Journal of Advanced Nursing. 2016;72(12):2954-65.
35. Brown MJ, Chuang-Stein C, Kirby S. Designing studies to find early signals of efficacy. J Biopharm Stat. 2012;22(6):1097-108.
36. Braun V, Clarke V. Using thematic analysis in psychology. Qualitative Research in Psychology. 2006;3(2):77-101.
37. Waaijman R, Keukenkamp R, de Haart M, Polomski WP, Nollet F, Bus SA. Adherence to Wearing Prescription Custom-Made Footwear in Patients With Diabetes at High Risk for Plantar Foot Ulceration. Diabetes care. 2013;36(6):1613-8.
38. Duley L, Gillman A, Duggan M, Belson S, Knox J, McDonald A, et al. What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK. Trials [Internet]. 2018 2018/01/08; 19(1):[15 p.]. Available from: https://doi.org/10.1186/s13063-017-2378-5.
39. Skea ZC, Treweek S, Gillies K. ‘It's trying to manage the work’: a qualitative evaluation of recruitment processes within a UK multicentre trial. BMJ Open [Internet]. 2017; 7(8):[e016475 p.]. Available from: https://bmjopen.bmj.com/content/bmjopen/7/8/e016475.full.pdf.
40. Paton JS, Stenhouse EA, Bruce G, Zahra D, Jones RB. A comparison of customised and prefabricated insoles to reduce risk factors for neuropathic diabetic foot ulceration: a participant-blinded randomised controlled trial. Journal Of Foot And Ankle Research [Internet]. 2012; 5(1):[31 p.].
41. Abbott CA, Chatwin KE, Foden P, Hasan AN, Sange C, Rajbhandari SM, et al. Innovative intelligent insole system reduces diabetic foot ulcer recurrence at plantar sites: a prospective, randomised, proof-of-concept study. The Lancet Digital Health [Internet]. 2019; 1(6):[e308-e18 pp.].
42. Bus S, Valk G, Van Deursen R, Armstrong D, Caravaggi C, Hlaváček P, et al. The effectiveness of footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in diabetes: a systematic review. Diabetes/metabolism research and reviews. 2008;24(S1):S162-S80.
43. Avery KNL, Williamson PR, Gamble C, O'Connell Francischetto E, Metcalfe C, Davidson P, et al. Informing efficient randomised controlled trials: exploration of challenges in developing progression criteria for internal pilot studies. BMJ Open. 2017;7(2):e013537.
44. Collings R, Freeman J, Latour JM, Paton J. Footwear and insole design features for offloading the diabetic at risk foot—A systematic review and meta-analyses. Endocrinology, Diabetes & Metabolism [Internet]. 2020 2020:[e00132 p.].
45. Vetter TR, Mascha EJ. Defining the Primary Outcomes and Justifying Secondary Outcomes of a Study: Usually, the Fewer, the Better. Anesth Analg. 2017;125(2):678-81.
46. Treweek S, Pitkethly M, Cook J, Fraser C, Mitchell E, Sullivan F, et al. Strategies to improve recruitment to randomised trials. Cochrane Database of Systematic Reviews [Internet]. 2018 Feb 22; 2:[Mr000013 p.].
47. Beidas RS, Cross W, Dorsey S. Show me, don’t tell me: Behavioral rehearsal as a training and analogue fidelity tool. Cognitive and Behavioral Practice. 2014;21(1):1-11.
48. An M, Dusing SC, Harbourne RT, Sheridan SM. What Really Works in Intervention? Using Fidelity Measures to Support Optimal Outcomes. Phys Ther. 2020;100(5):757-65.